PAPER Masciopinto F, Di Pietro N, Corona C, Bomba M, Pipino C, Curcio M, Di Castelnuovo A, Ciavardelli D, Silvestri E, Canzoniero LM, Sekler I, Pandolfi A, Sensi SL
SEARCH RESULTS
331873 RESULTS
PAPER Olsson B, Hertze J, Ohlsson M, Nägga K, Höglund K, Basun H, Annas P, Lannfelt L, Andreasen N, Minthon L, Zetterberg H, Blennow K, Hansson O
Cerebrospinal fluid levels of heart fatty acid binding protein are elevated prodromally in Alzheimer's disease and vascular dementia.
J Alzheimers Dis. 2013;34(3):673-9. PubMed: 23254629PAPER Ancelin ML, Ripoche E, Dupuy AM, Barberger-Gateau P, Auriacombe S, Rouaud O, Berr C, Carrière I, Ritchie K
Sex differences in the associations between lipid levels and incident dementia.
J Alzheimers Dis. 2013 Jan 1;34(2):519-28. PubMed: 23254630PAPER Schmid NS, Taylor KI, Foldi NS, Berres M, Monsch AU
Neuropsychological signs of Alzheimer's disease 8 years prior to diagnosis.
J Alzheimers Dis. 2013 Jan 1;34(2):537-46. PubMed: 23254631PAPER Royall DR, Palmer RF, Vidoni ED, Honea RA
The Default Mode Network may be the Key Substrate of Depressive Symptom-Related Cognitive Changes.
J Alzheimers Dis. 2013 Jan 1;34(2):547-59. PubMed: 23254633PAPER Recuero M, Munive VA, Sastre I, Aldudo J, Valdivieso F, Bullido MJ
A Free Radical-Generating System Regulates AβPP Metabolism/Processing: Involvement of the Ubiquitin/Proteasome and Autophagy/Lysosome Pathways.
J Alzheimers Dis. 2013 Jan 1;34(3):637-47. PubMed: 23254632PAPER Kim B, Backus C, Oh S, Feldman EL
Hyperglycemia-Induced Tau Cleavage in vitro and in vivo: A Possible Link Between Diabetes and Alzheimer's Disease.
J Alzheimers Dis. 2013 Jan 1;34(3):727-39. PubMed: 23254634PAPER Dieks JK, Gawinecka J, Asif AR, Varges D, Gmitterova K, Streich JH, Dihazi H, Heinemann U, Zerr I
Low-abundant cerebrospinal fluid proteome alterations in dementia with lewy bodies.
J Alzheimers Dis. 2013 Jan 1;34(2):387-97. PubMed: 23254635PAPER O'Bryant SE, Johnson L, Edwards M, Soares H, Devous MD, Ross S, Rohlfing G, Hall J
The link between C-reactive protein and Alzheimer's disease among mexican americans.
J Alzheimers Dis. 2013 Jan 1;34(3):701-6. PubMed: 23254637PAPER Won JS, Kim J, Annamalai B, Shunmugavel A, Singh I, Singh AK
Protective Role of S-Nitrosoglutathione (GSNO) Against Cognitive Impairment in Rat Model of Chronic Cerebral Hypoperfusion.
J Alzheimers Dis. 2013 Jan 1;34(3):621-35. PubMed: 23254638PAPER Defrancesco M, Marksteiner J, Deisenhammer E, Kemmler G, Djurdjevic T, Schocke M
Impact of white matter lesions and cognitive deficits on conversion from mild cognitive impairment to Alzheimer's disease.
J Alzheimers Dis. 2013 Jan 1;34(3):665-72. PubMed: 23254639PAPER Choi JH, Kaur G, Mazzella MJ, Morales-Corraliza J, Levy E, Mathews PM
Early Endosomal Abnormalities and Cholinergic Neuron Degeneration in Amyloid-β Protein Precursor Transgenic Mice.
J Alzheimers Dis. 2013 Jan 1;34(3):691-700. PubMed: 23254640PAPER Heneka MT, Kummer MP, Stutz A, Delekate A, Schwartz S, Vieira-Saecker A, Griep A, Axt D, Remus A, Tzeng TC, Gelpi E, Halle A, Korte M, Latz E, Golenbock DT
NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS1 mice.
Nature. 2013 Jan 31;493(7434):674-8. Epub 2012 Dec 19 PubMed: 23254930PAPER Wright O, Zhang L, Liu Y, Yoshimi T, Zheng Y, Tunnacliffe A
Critique of the use of fluorescence-based reporters in Escherichia coli as a screening tool for the identification of peptide inhibitors of Aβ42 aggregation.
J Pept Sci. 2013 Feb;19(2):74-83. PubMed: 23255255PAPER Giorgio A, De Stefano N
Clinical use of brain volumetry.
J Magn Reson Imaging. 2013 Jan;37(1):spcone. PubMed: 23255415Current Filters
No filters selected